KLA Corporation FY2026 Annual Report, September 2026
KLA's FY2026 10-K filing confirms revenue of $13.58 billion with capital expenditure rising 12.1% to $376 million, underscoring an asset-light process-control model built to compound through the AI-driven fab expansion cycle.
- 최근 회계연도 설비투자
- $376M (FY2026)
- 전년 대비
- 12.1% · $335M → $376M
- 투자 / 매출
- 3% (FY2026, $13.58B)
- 최고 기록 기간
- $96M · 2025-09-30
KLA Corporation's filing of its fiscal 2026 annual report with the SEC on September 9 — preceded by an August 7 8-K that Slicast classified as a first-hand capital expenditure cycle disclosure, and accompanied by a cluster of additional 8-K current reports spanning late July through early September — marks a natural checkpoint for assessing where the world's preeminent semiconductor process-control company stands as the AI infrastructure buildout enters its most capital-intensive phase. The cadence of filings itself is unremarkable for a large-cap at the close of its fiscal year, but the aggregate picture they paint is worth examining in detail.
The headline from Slicast's XBRL-derived capex compilation is instructive on its own terms: capital expenditure reached $376 million in FY2026, up 12.1% from $335 million in FY2025, against revenue of $13.58 billion — implying a capex intensity of just 3%. Within the chip sector as Slicast tracks it, that ranks KLA fourteenth of fifteen peers by intensity, with Micron leading the category at the opposite end of the spectrum. The apparent parsimony is not a weakness; it is the signature of the asset-light model that defines equipment and process-control companies. KLA designs and sells the tools that detect nanometer-scale defects on silicon wafers; it does not run the fabs that consume them. Its largest customers — TSMC, Samsung, SK Hynix, Micron, and Intel — absorb the heavy depreciation of cleanroom infrastructure while KLA converts intellectual property and service relationships into structurally high-margin recurring revenue. The $96 million in capex recorded in the quarter ended September 30, 2025, the highest single-period figure in Slicast's 69-quarter coverage history back to 2009, points to selective investment in KLA's own R&D infrastructure and manufacturing capacity rather than any departure from that discipline.
The strategic significance of the annual report goes beyond any single line item. Process control accounts for roughly a tenth of all wafer-fab equipment spending, and KLA is estimated to hold a commanding share of that segment, particularly in wafer inspection and reticle qualification. As leading-edge nodes tighten — TSMC's N2 production ramp and Samsung's 3-nanometer yield improvement programs both require more inspection steps per wafer start than the nodes they succeed — KLA's revenue per wafer start compounds upward even before unit volumes expand. The AI GPU and high-bandwidth memory demand driving headline semiconductor investment translates, further back in the supply chain, into incremental process-control tool orders that arrive on KLA's books with multi-quarter lag. Viewed through that lens, FY2026 revenue of $13.58 billion reflects capacity already ordered by fabs investing in today's AI acceleration wave, while forward order books will increasingly reflect the next round of node transitions.
Two structural risks deserve equal weight alongside the opportunity. Export-control policy is the most immediate: U.S. restrictions on advanced semiconductor equipment exports to China, tightened incrementally since late 2022, have required KLA to seek export licenses for a portion of its product portfolio bound for Chinese customers. China has represented a meaningful share of global wafer-fab equipment demand in recent years, and any further restriction — or Chinese countermeasures affecting access to specialty materials and precursors — could compress KLA's addressable market in ways that take multiple earnings cycles to offset through wins in Japan, South Korea, and Europe. Second, semiconductor equipment spending is inherently cyclical: memory customers in particular have a history of sharp capex compression during inventory corrections, and while the current AI-driven cycle has extended longer than prior cycles would have predicted, the risk of demand softening at hyperscalers or delayed DRAM and NAND investment cannot be dismissed on the basis of current momentum alone.
Investors watching KLAC at $182.91, down 3.2% on the day of this writing, should track three concrete signals in the quarters ahead. First, the pace of advanced-node tool orders from TSMC and Samsung as their respective N2 and next-generation 3-nanometer yields progress — a leading indicator for KLA's forward revenue more reliable than any single quarter's bookings. Second, the scope of U.S. export-licensing decisions as they surface in successive earnings calls, particularly any change in the China revenue mix that management chooses to disclose explicitly. Third, whether KLA's own capex intensity sustains its modest upward trend: a durable move above the 3% FY2026 baseline would signal meaningful technology-cycle investment in EUV-compatible inspection and high-NA overlay metrology — the capabilities that will determine who captures process-control share at the 1.4-nanometer node and beyond. For now, the FY2026 annual report documents a business in strong competitive position, with the financial discipline and intellectual-property depth to benefit from the AI buildout without having to bet the balance sheet on it.